Indeed, deeper understanding of the biology of PCa has been gained through investigating different molecular changes throughout the natural history of PCa and identifying the high prevalence of somatic and/or germline HRR mutations, e.g. alterations in BRCA1, BRCA2 and ATM genes. The gene discussed is BRCA2; the disease is posterior cortical atrophy.